Abstract:Abstract Background Epigenetic alterations contribute greatly to metastasis and dissemination in hepatocellular carcinoma (HCC). SMARCC1, as a SWI/SNF chromatin remodeling factor, has been reported to play important roles in many cancers. For the first time, with the bioinformatics analysis and wet-bench experiments, we explored the biological significance of SMARCC1 and its potential as putative therapeutic target in HCC. Methods The mRNA expression profiles and prognostic value of SMARCC1 were analyzed in the Oncomine, UALCAN and Kaplan–Meier Plotter databases. The expression of SMARCC1 and associated clinicopathological factors were further evaluated using a tissue microarray. Differentially expressed genes associated with SMARCC1 in HCC were obtained and analyzed via the LinkedOmics and GEPIA databases and Cytoscape software. To verify the important role of SMARCC1 in HCC, we knocked down and overexpressed SMARCC1 in different hepatic cell lines and conducted several functional experiments. Then, we evaluated the mutation profiles and transcriptional regulators of SMARCC1 using the cBioPortal, COSMIC, CistromeDB and TCGA databases. Finally, we addressed the relationship of SMARCC1 expression with immune cell infiltration via TIMER database analysis. Results Through data mining and tissue microarray verification, we found that the protein and mRNA levels of SMARCC1 are high in tumor tissues, which has remarkable diagnostic value in HCC patients. SMARCC1 and its hub genes showed prognostic value in HCC. Furthermore, we confirmed that SMARCC1 influenced the proliferation, migration, and invasion of HCC cells. Moreover, correlation analyses revealed that SMARCC1 expression was positively correlated with ZBTB40 transcription factors and negatively correlated with the DNA methylation level. Overall, we found that SMARCC1 affects immune infiltration and plays a tumor-promoting role in HCC. Conclusions SMARCC1 is overexpressed and is a putative prognostic predictor in HCC. Due to the tumor-promoting role of SMARCC1, treatments inhibiting DNA methyltransferases and transcription factors or weakening the role of SMARCC1 in immune infiltration might improve the survival of HCC patients.

SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis Through Wnt/beta-catenin-Mediated EMT

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

Long Non-Coding RNA DSCAM-AS1 Promotes Pancreatic Cancer Progression Via Regulating the Mir-136-5p/pbx3 Axis

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Over‐expression of FoxM1 Leads to Epithelial–mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells

Biological Characteristics of Pancreatic Ductal Adenocarcinoma: Initiation to Malignancy, Intracellular to Extracellular.

Β-Catenin is a Promising Key Factor in the SDF-1/CXCR4 Axis on Metastasis of Pancreatic Cancer

Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling

MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells

KLK10/LIPH/PARD6B/SLC52A3 Are Promising Molecular Biomarkers for the Prognosis of Pancreatic Cancer Through a Cerna Network

Identification of SMARCA1 as a key regulator for Colorectal Cancer

Prometastatic Mechanisms of Caf-Mediated Emt Regulation in Pancreatic Cancer Cells

SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis

BRM/SMARCA2 Promotes the Proliferation and Chemoresistance of Pancreatic Cancer Cells by Targeting JAK2/STAT3 Signaling

The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression

The Regulatory Role of SNORD35A in Pancreatic Cancer Involves the HGF/C-Met Pathway

Macc1: A Potential Molecule Associated With Pancreatic Cancer Metastasis And Chemoresistance

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma

Polycomb Complex Protein Bmi-1 Promotes Invasion and Metastasis of Pancreatic Cancer Stem Cells by Activating Pi3k/Akt Signaling, an Ex Vivo, in Vitro, and in Vivo Study